Ratings Mettler-Toledo International, Inc.

Equities

MTD

US5926881054

Market Closed - Nyse Other stock markets 04:00:02 2024-05-17 pm EDT			5-day change	1st Jan Change
1,523 ^USD	-0.51%		+0.83%	+25.54%

May. 16	Mettler Toledo International Insider Sold Shares Worth $468,584, According to a Recent SEC Filing	MT
May. 15	Mettler Toledo International Insider Sold Shares Worth $2,994,661, According to a Recent SEC Filing	MT

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
The group's activity appears highly profitable thanks to its outperforming net margins.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
With an expected P/E ratio at 40.15 and 35.56 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The company's "enterprise value to sales" ratio is among the highest in the world.
The company is highly valued given the cash flows generated by its activity.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.	ESG Refinitiv
METTLER-TOLEDO INTERNATIONAL, INC.	+25.54%	32.52B	B
ABBOTT LABORATORIES	-5.43%	181B	C+
MEDTRONIC PLC	+4.30%	114B	C
BECTON, DICKINSON AND COMPANY	-3.09%	68.29B	A
DEXCOM, INC.	+5.86%	52.24B	B-
CENCORA, INC.	+8.15%	44.3B	B-
HOYA CORPORATION	+7.52%	42.73B	B+
TERUMO CORPORATION	+17.85%	26.02B	A-
WEST PHARMACEUTICAL SERVICES, INC.	+1.00%	25.91B	A-
ZIMMER BIOMET HOLDINGS, INC.	-1.25%	24.72B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes